Selling Zone: SP500 Levels, Refreshed

POSITIONS: Long Healthcare (XLV) Long Consumer Discretionary (XLY), Short Industrials (XLI)


I came into today a lot longer than I am now. I sold by my SPY and AAPL as we push toward my Selling Zone.


Since Equity Volatility has moved back to bullish TRADE and TREND, I can change the duration and volume assumptions in my immediate-term TRADE calculation in order to generate a range of probabilities instead of a point.


In other words, there are 2 immediate-term TRADE lines (1315 and 1329), and that generates my Selling Zone. On the way up towards that zone I want to be selling longs first, then re-shorting best ideas, selectively.


Across risk management durations that matter most, here are my lines right now: 

  1. Intermediate-term TREND resistance = 1369
  2. Immediate-term TRADE zone = 1
  3. Long-term TAIL support = 1282 

We held my long-term TAIL of 1282, and that’s the most bullish thing I can tell you. But I am also telling you to sell down gross and/or net exposure on the way up. Unless we see  a close > 1369, the intermediate-term view for Q2 remains bearish.


Keep moving out there,



Keith R. McCullough
Chief Executive Officer


Selling Zone: SP500 Levels, Refreshed - SPX

CRI: Shorting


Keith just added CRI on the short side of the Hedgeye Virtual Portfolio. CRI remains one of our top short ideas across all durations, as outlined in our May 9th report “CRI: Short It”. Sales growth is slowing, underappreciated margin pressures are intensifying, and its largest holder is selling.  


We've included our May 9th note below.


CRI: Shorting - CRI TTT


5/9/2012 11:29 pm

CRI: Short it


Nearly all the factors that kept this stock grinding higher while estimates came down last year are either slowing, or flat-out reversing, on the margin. We really like the 3/1 odds on the short side.

We think Carter’s is shaping up as a short again. After nearly a year of perceived positive factors at its back, we think that opacity related to organic earnings power will be gone, and competitive challenges will emerge at a time when it is shifting away from harvesting its prior investments, and will need to put capital in to its model that will put a ceiling on margin improvement at a minimum, and likely create meaningful downside if our industry call for increased competition and margin pressure comes to fruition. With that, sales deceleration is a near certainty barring another acquisition, and valuation is sitting near the seven-year peak.

We say ‘shaping up as a short again’ with full awareness that it did not do what we thought it should have done in 2011. In fact, we went into 2011 with estimates for the year at $1.75 and the consensus at $2.40. By year’s end, the Street came down, and down and down by 21%, and CRI earned an adjusted $1.94 (before $0.15 Bonnie Togs accretion). Yet the stock literally defied gravity and went the exact opposite direction – gaining 35% for the year (vs. virtually flat performance for S&P, RTH and the MVRX).


If there’s one rule of retail investing that we’ve learned over time, it’s that earnings revision is the key factor in determining the direction of a stock. Pull up thefunction on your bloomberg. With 9 stocks out of 10, you’re going to see that the stock price tracks (or leads) earnings in a very tight band.  Take a look at NKE, AAPL, GIL earnings revisions vs. the stock (all courtesy of Bloomberg).




CRI: Shorting - NKE for CRI




CRI: Shorting - AAPL for CRI




CRI: Shorting - GIL for CRI


Now look at CRI. HUH?


CRI: Shorting - CRI for CRI


Whenever we talked to people about this name, we were given the same bull factors ad nauseam:

1)  The company had the toughest COGS comps in 2H11, in advance of which it took up prices by 10%. In doing the math, a 10% increase on a $10 product at retail almost entirely outweighs a 25% increase in a $3-4 product cost.

2)  At the same time, CRI was boosting its off-price sales from 1% of total in 2010 to 4% in 2011, and while this would ordinarily be dilutive to margins, it was enough to help leverage SG&A.

3)  While both of these two factors played out, CRI benefitted from the addition of the Bonnie Togs acquisition, which boosted sales by an average of 6% per quarter – again, a factor that (with some minor cuts to acquired SG&A) helped leverage SG&A at the greatest rate in nearly a decade.

4)  And how could we forget the ultimate response?  “The market is flat, I’m clawing to hang on to my return/loss for the year, and you expect me to short the stock of a company that Berkshire Partners is not-so-slowly taking private?


Now what have we got?

1)  The good news is that CRI starts to anniversary its higher product costs (that’s the bull case), but unfortunately, it starts to anniversary its pricing initiatives as well. It’s all too often that people adjust one without the other. There are, after all, two components to gross margin. Costs are forecastable. But prices to consumers – especially for a company where 40% of sales come from vertically-owned-retail – are DEFINITELY not.

2)  Off price sales should come down from 4% of sales last year, to about 2% this year. Yes, that’s good for gross margin. But on top of other factors impacting top line, it will make any form of SG&A leverage very difficult.

3)  Bonnie Togs is still there. But it is officially anniversaried. Now it and Carter’s each need to grow on their own without the benefit of basic acquisition accounting helping the situation.

4)  Expectations are lofty – at or above company guidance for sales and EPS.

    • Revenue: Consensus at $2,370mm – ABOVE guidance of $2,300mm – $2,342mm.  
    • EPS: 2012 Consensus at $2.61 – ABOVE guidance of $2.51-$2.61                                        
      • Consensus EPS of $3.28 for 2013, and $3.63 for 2014. We’re at $2.70 and $3.00, respectively.                                                 
      • With all these other factors no longer in CRI’s favor, we have a tough time stomaching the premise that thechart on bloomberg maintains its scant correlation under these circumstances with a 20% earnings reduction.                                                           
      • If our estimates prove right, there’s no reason this stock can’t see the low-mid $30s. But under the most bullish consensus expectations, we still have a tough time getting this name in the upper $50s. We like the 3/1 odds of a short here.

 5)  And lastly…the “Berkshire is Buying” argument is pretty much dead in the water. Yes, they’re selling on the margin.



Historical context is important here...


We were asked a couple of weeks ago by a top client as to why CRI traded at such a high EV/Sales ratio (2.1x) circa 2005. Our answer sounded something like this:


This was when CRI achieved cult stock status. There were several factors, all related to post IPO action.


The pitch on the IPO was…

a)  Shift away from basics into playwear

b)  Shift from traditional dept store biz to serving 1) mass channels, and 2) company-owned retail.

c)  CRI had new arrangements with Li&Fung – through which it cut its sourcing costs by nearly 1/3 and passed right through to consumers in the form of lower prices to gain share.

d)  Remember that this period (ending April 2007 when LIZ went Ka-Boom) was easy for apparel retail. You could be an average brand and run at peak margins without much effort. The environment allowed CRI to sell into three completely distinct channels with like product without stepping on each other’s toes – and the Street was not only oblivious, but it also gave CRI’s multiple credit for this as a big positive.

e)  Then in 2005 CRI bought Osh Kosh. In the ensuing 2-years, they cut employee count from 400 to less than 100. Margins went up temporarily, before growth slowed and the story became outwardly and visibly broken.

f)  Pretty soon thereafter, people realized that this name was not infallible – that it can’t sell the same stuff through Target, Kohl’s, Macy’s and its own stores -- and that it can’t cut costs to keep margins high in the face of slowing growth.
g)  Fred Rowan (CEO) got fired in 2008, and since then, the Mike Casey era has taken hold. Definitely a better regime. But there was just as much financial engineering as anything else (he was former CFO). CRI had to button up policies due to a markdown irregularity accounting issue w KSS, as well as an exec being charged with fraud and insider trading by SEC in 2010. Nonetheless, it’s got a long way to go before it’s worthy of ‘cult stock’ status again. Our point is that today it is sitting at 1.25x EV/Sales. That’s well below the prior peak of 2.1x, but the old peak is just that…the OLD peak. It need not apply any more.

Playwear has nearly doubled as a percent of CRI’s total over the past ten years. ‘Baby’ is a very defendable business – the Carter’s brand goes a long way with a new Mom swaddling her newborn. But in the Playwear category, it competes with everything from Children’s place, to Old Navy, to JC Penney and Wal-Mart private label. Not a place to hang your hat on.


 CRI: Shorting - CRI category mix

European Banking Monitor: Flashing Red

European Banking Monitor: Flashing Red


Below are key European banking risk monitors, which are included as part of Josh Steiner and the Financial team's "Monday Morning Risk Monitor".  If you'd like to receive the work of the Financials team or request a trial please email .

Key Takeaways:


* Default probabilities rising globally. European sovereign CDS widened across the board last week. Similarly, nearly all European Bank credit default swaps widened last week. Italian and French banks saw their spreads widen by double digits WoW. Domestic bank CDS followed suit. 


If you’d like to discuss recent developments in Europe, from the political to financial to social, please let me know and we can set up a call.


Matthew Hedrick

Senior Analyst




European Financials CDS Monitor – Bank swaps were wider in Europe last week for 38 of the 39 reference entities we track. Notably, French banks widened dramatically. Societe Generale widened by 65 bps to 402 bps while Credit Agricole widened by 69 bps to 404 bps. The debt markets are casting their vote on the outcome of the French elections. Meanwhile, Italian bank swaps weren't far behind with increases of 48 to 97 bps week-over-week. Spanish banks were wider as well, though more modestly than their French or Italian counterparts.


We've also included a few Chinese banks for reference at the bottom of the table, and we will be soon rolling a table of Asian Financial CDS. The three Chinese banks we track showed week over week increases, but are generally trading in the low-200 bps range.  


European Banking Monitor: Flashing Red - cc. banks


Euribor-OIS spread – The Euribor-OIS spread (the difference between the euro interbank lending rate and overnight indexed swaps) measures bank counterparty risk in the Eurozone. The OIS is analogous to the effective Fed Funds rate in the United States.  Banks lending at the OIS do not swap principal, so counterparty risk in the OIS is minimal.  By contrast, the Euribor rate is the rate offered for unsecured interbank lending.  Thus, the spread between the two isolates counterparty risk. The Euribor-OIS spread was roughly flat over last week, ending the week at 38 bps.


European Banking Monitor: Flashing Red - cc. euribor


ECB Liquidity Recourse to the Deposit Facility – The ECB Liquidity Recourse to the Deposit Facility measures banks’ overnight deposits with the ECB.  Taken in conjunction with excess reserves, the ECB deposit facility measures excess liquidity in the Euro banking system.  An increase in this metric shows that banks are borrowing more from the ECB.  In other words, the deposit facility measures one element of the ECB response to the crisis.  The latest overnight reading is €789.71B.


European Banking Monitor: Flashing Red - cc. ecb


Security Market Program – For a tenth straight week the ECB's secondary sovereign bond purchasing program, the Securities Market Program (SMP), purchased no sovereign paper for the latest week ended 5/18, to take the total program to €212 Billion.


European Banking Monitor: Flashing Red - cc. smp

get free cartoon of the day!

Start receiving Hedgeye's Cartoon of the Day, an exclusive and humourous take on the market and the economy, delivered every morning to your inbox

By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails.


We have been hammering home the BWLD idea since early January.  Our CEO Keith McCullough just shorted BWLD and we will be highlighting the BWLD idea on our best ideas call Wednesday May 23rd at 11am.  Contact if you want to listen.  


The BWLD thesis: This stock is highly valued as it one of the few “growth” plays in casual dining.  The year-over-year increase in wing prices has a direct impact on EPS that we believe consensus is underestimating.  We expect negative FY12 EPS revisions over the next two-three months.




Lowering our May forecast to HK$25.5-26.5 billion or 8-12% YoY growth



Average daily table revenues (ADTR) increased slightly from last week, HK$714 million to HK729 million, but should’ve been better.  ADTR was actually down 6% YoY.  As a result, we are lowering our full month forecast to HK$25.5-26.5 billion, representing only 8-12% YoY growth.  At this time, we don’t know what kind of impact hold has played. 




For market share, LVS improved its monthly performance by 50bps but is still well below the 19-20% share it should be garnering following the opening of Sands Cotai Central.  MPEL’s share dropped to 12.3% which is 100-150bps below recent trend.  Galaxy continues to surprise on the upside as does SJM.  Wynn picked up some sequential share but is still well below trend.




The Macau Metro Monitor, May 19, 2012




Macau CPI for April 2012 increased by 6.76% YoY and 0.61% MoM.

investing ideas

Risk Managed Long Term Investing for Pros

Hedgeye CEO Keith McCullough handpicks the “best of the best” long and short ideas delivered to him by our team of over 30 research analysts across myriad sectors.